v3.26.1
Consolidated Statements of Changes in Equity
$ in Millions
USD ($)
shares
Issued capital [member]
USD ($)
shares
Share Premium
USD ($)
Retained Earnings
USD ($)
Other Reserves
USD ($)
 [1]
Capital Redemption Reserve
USD ($)
Cash Flow Hedge Reserve
USD ($)
Other Components of Equity
USD ($)
Total equity attributable to equity holders of the company
USD ($)
Non-controlling interest
USD ($)
Balance at Mar. 31, 2023 $ 9,224 $ 325 $ 366 $ 11,401 $ 1,370 $ 24   $ (4,314) $ 9,172 $ 52
Balance, Shares at Mar. 31, 2023 | shares [2]   4,136,387,925                
Changes in equity for the year                    
Net Profit 3,169     3,167         3,167 2
Remeasurement of the net defined benefit liability/asset, net* [3] 15             15 15  
Equity instruments through other comprehensive income, net* (Refer to Notes 2.2 and 2.18) [3] 2             2 2  
Fair value changes on investments, net* (Refer to Notes 2.2 and 2.18) [3] 17             17 17  
Fair value changes on derivatives designated as cash flow hedge, net* (Refer to Notes 2.3 and 2.18) [3] 1           $ 1   1  
Exchange differences on translation of foreign operations (117)             (116) (116) (1)
Total comprehensive income 3,087     3,167     1 (82) 3,086 1
Shares issued on exercise of employee stock options (Refer to note 2.17) 1   1           1  
Shares issued on exercise of employee stock options (Refer to note 2.17), Shares | shares [2]   3,562,710                
Transferred on account of options not exercised     (19) 19            
Transfer to other reserves       (357) 357          
Transfer from other reserves on utilization       104 (104)          
Employee stock compensation expense (Refer to note 2.17) 77   77           77  
Buyback of shares pertaining to non controlling interest of subsidiary (2)                 (2)
Dividends paid to non-controlling interest of subsidiary (5)                 (5)
Dividends [3] (1,777)     (1,777)         (1,777)  
Balance at Mar. 31, 2024 10,605 $ 325 425 12,557 1,623 24 1 (4,396) 10,559 46
Balance, Shares at Mar. 31, 2024 | shares [2]   4,139,950,635                
Changes in equity for the year                    
Net Profit 3,162     3,158         3,158 4
Remeasurement of the net defined benefit liability/asset, net* [3] (11)             (11) (11)  
Equity instruments through other comprehensive income, net* (Refer to Notes 2.2 and 2.18) [3] 2             2 2  
Fair value changes on investments, net* (Refer to Notes 2.2 and 2.18) [3] 24             24 24  
Fair value changes on derivatives designated as cash flow hedge, net* (Refer to Notes 2.3 and 2.18) [3] (3)           (3)   (3)  
Exchange differences on translation of foreign operations (198)             (198) (198)  
Total comprehensive income 2,976     3,158     (3) (183) 2,972 4
Shares issued on exercise of employee stock options (Refer to note 2.17) 1   1           1  
Shares issued on exercise of employee stock options (Refer to note 2.17), Shares | shares [2]   3,656,893                
Transferred on account of options not exercised     (23) 23            
Transfer to other reserves       (9) 9          
Transfer from other reserves on utilization       104 (104)          
Employee stock compensation expense (Refer to note 2.17) 93   93           93  
Income tax benefit arising on exercise of stock options (Refer to note 2.12) 4   4           4  
Transferred from other reserves to retained earnings       357 (357)          
Dividends [3] (2,424)     (2,424)         (2,424)  
Balance at Mar. 31, 2025 $ 11,255 $ 325 500 13,766 1,171 24 (2) (4,579) 11,205 50
Balance, Shares at Mar. 31, 2025 | shares 4,143,607,528 4,143,607,528 [2]                
Changes in equity for the year                    
Net Profit $ 3,316     3,313         3,313 3
Remeasurement of the net defined benefit liability/asset, net* [3] (31)             (31) (31)  
Equity instruments through other comprehensive income, net* (Refer to Notes 2.2 and 2.18) [3] 42             42 42  
Fair value changes on investments, net* (Refer to Notes 2.2 and 2.18) [3] (2)             (2) (2)  
Exchange differences on translation of foreign operations (684)             (685) (685) 1
Total comprehensive income 2,641     3,313       (676) 2,637 4
Shares issued on exercise of employee stock options (Refer to note 2.17), Shares | shares [2]   3,333,284                
Buyback of equity shares (Refer to Note 2.15) (2,021) $ (6) (140) (1,875)         (2,021)  
Buyback of equity shares (Refer to Note 2.15), Shares | shares [2]   (100,000,000)                
Transaction costs related to buyback* (Refer to Note 2.15) [3] (5)   (2) (3)         (5)  
Amount transferred to capital redemption reserve upon buyback (Refer to Note 2.15)       (6)   6        
Financial liability under option arrangements (1)     (1)         (1)  
Changes in the controlling stake of a subsidiary 1     1         1  
Transferred on account of options not exercised     (7) 7            
Transfer from other reserves on utilization       139 (139)          
Employee stock compensation expense (Refer to note 2.17) 106   106           106  
Income tax benefit arising on exercise of stock options (Refer to note 2.12) 5   5           5  
Transferred from other reserves to retained earnings       259 (259)          
Dividends [3] (2,141)     (2,141)         (2,141)  
Balance at Mar. 31, 2026 $ 9,840 $ 319 $ 462 $ 13,459 $ 773 $ 30 $ (2) $ (5,255) $ 9,786 $ 54
Balance, Shares at Mar. 31, 2026 | shares 4,046,940,812 4,046,940,812 [2]                
[1] Represents the Special Economic Zone Re-investment reserve created out of the profit of the eligible SEZ unit in terms of the provisions of Sec 10AA(1)(ii) of Income Tax Act,1961. The reserve should be utilized by the Group for acquiring new plant and machinery for the purpose of its business in terms of the provisions of the Sec 10AA(2) of the Income Tax Act, 1961.
[2] excludes treasury shares of 8,650,911 as of March 31, 2026, 9,655,927 as of March 31, 2025, 10,916,829 as of March 31, 2024, and 12,172,119 as of April 1, 2023, held by consolidated trust.
[3] net of taxes